-transparent.png){kind=logo}
Nocardicin A is a new monocyclic beta-lactam antibiotic which provides a potent therapeutic effect in mice experimentally infected with gram-negative bacilli. When given subcutaneously to mice, the therapeutic effect of the drug was stronger than had been anticipated from in vitro studies. Nocardicin A was more potent in therapeutic effect than carbenicillin against infections due to Pseudomonas aeruginosa, Proteus mirabilis, Pr. vulgaris, Pr. rettgeri and Pr. inconstans, and was similar in effect to carbenicillin against infections due to Escherichia coli in mice. In addition, nocardicin A proved to be active against infections due to Serratia marcescens and other organisms resistant to beta-lactam antibiotics. When nocardicin A was given subcutaneously to mice, blood and hepatic levels of the drug were higher than those of carbenicillin.
Y Mine, and
S Nonoyama, and
H Kojo, and
S Fukada, and
M Nishida
January 1988,
Microbiology and immunology,
Y Mine, and
S Nonoyama, and
H Kojo, and
S Fukada, and
M Nishida
May 1976,
The Journal of antibiotics,
Y Mine, and
S Nonoyama, and
H Kojo, and
S Fukada, and
M Nishida
November 1977,
The Journal of antibiotics,
Y Mine, and
S Nonoyama, and
H Kojo, and
S Fukada, and
M Nishida
July 2004,
Chemistry & biology,
Y Mine, and
S Nonoyama, and
H Kojo, and
S Fukada, and
M Nishida
September 1976,
The Journal of antibiotics,
Y Mine, and
S Nonoyama, and
H Kojo, and
S Fukada, and
M Nishida
February 1985,
The American journal of medicine,
Y Mine, and
S Nonoyama, and
H Kojo, and
S Fukada, and
M Nishida
December 1992,
Chemical & pharmaceutical bulletin,
Y Mine, and
S Nonoyama, and
H Kojo, and
S Fukada, and
M Nishida
June 1985,
Danish medical bulletin,
Y Mine, and
S Nonoyama, and
H Kojo, and
S Fukada, and
M Nishida
May 1976,
Journal of the American Chemical Society,
Y Mine, and
S Nonoyama, and
H Kojo, and
S Fukada, and
M Nishida
May 1985,
Antimicrobial agents and chemotherapy,
